111614
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
用于炎症疾病的天然、工程化及杂化血小板膜基纳米治疗剂
Authors Liu B , Wang Y, Gong W, Han S, Lv Z, Zhang Z, Qi J, Song A, Yang Z, Duan L, Zhang T, Wang Z
Received 6 August 2025
Accepted for publication 13 November 2025
Published 26 November 2025 Volume 2025:20 Pages 14149—14184
DOI https://doi.org/10.2147/IJN.S558928
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Jie Huang
Boyuan Liu,1,* Yongjie Wang,1– 3,* Weiquan Gong,1 Song Han,1 Zhenshan Lv,1 Zilin Zhang,1 Jinwei Qi,1 Aijun Song,1 Zongyuan Yang,1 Longfei Duan,1 Tianhui Zhang,1 Zhenyu Wang1
1Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China; 2Department of Orthopedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, People’s Republic of China; 3Department of Orthopaedics, Wenzhou Medical University Affiliated Taizhou Central Hospital, Taizhou, Zhejiang, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhenyu Wang, Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China, Email zhenyu@jlu.edu.cn
Abstract: Nanotherapeutics based on platelet membranes represent a new and advanced biomimetic approach in nanomedicine. By covering synthetic nanoparticle cores with natural platelet membranes, these platforms ingeniously combine the multifaceted biointerfacing abilities of platelets, such as long circulation, immune evasion, and targeting of inflamed tissues, with the many functions of engineered cores. This review systematically summarizes recent advances in the design and application of nanotherapeutics, categorizing them into three platforms: those derived from natural platelet membranes, those utilizing engineered platelet membranes for enhanced targeting or drug loading, and those employing hybrid membranes fused with other cell types to combine complementary functionalities. We emphasize their therapeutic efficacy in various inflammatory diseases such as atherosclerosis, ischemic injury (stroke and myocardial infarction), rheumatoid arthritis, microbial infections, and the tumor inflammatory microenvironment. Finally, we discuss the translational potential and current challenges of this technology and provide a critical perspective on its future development in precision medicine.
Keywords: platelet membrane, engineered platelet, hybrid membrane, inflammation, nanotherapy
1Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China; 2Department of Orthopedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, People’s Republic of China; 3Department of Orthopaedics, Wenzhou Medical University Affiliated Taizhou Central Hospital, Taizhou, Zhejiang, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhenyu Wang, Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin, People’s Republic of China, Email zhenyu@jlu.edu.cn
Abstract: Nanotherapeutics based on platelet membranes represent a new and advanced biomimetic approach in nanomedicine. By covering synthetic nanoparticle cores with natural platelet membranes, these platforms ingeniously combine the multifaceted biointerfacing abilities of platelets, such as long circulation, immune evasion, and targeting of inflamed tissues, with the many functions of engineered cores. This review systematically summarizes recent advances in the design and application of nanotherapeutics, categorizing them into three platforms: those derived from natural platelet membranes, those utilizing engineered platelet membranes for enhanced targeting or drug loading, and those employing hybrid membranes fused with other cell types to combine complementary functionalities. We emphasize their therapeutic efficacy in various inflammatory diseases such as atherosclerosis, ischemic injury (stroke and myocardial infarction), rheumatoid arthritis, microbial infections, and the tumor inflammatory microenvironment. Finally, we discuss the translational potential and current challenges of this technology and provide a critical perspective on its future development in precision medicine.
Keywords: platelet membrane, engineered platelet, hybrid membrane, inflammation, nanotherapy